Hamilton Morris Confirmed as Keynote Speaker at Convergence Psychedelic Conference
Convergence, the biggest psychedelic culture and business conference in California, recently announced that Hamilton Morris would be a keynote speaker at the conference. Morris is a well-known advocate in the psychedelics space. In addition to being a scientific researcher, a journalist and a filmmaker, he has a television show known as “Hamilton’s Pharmacopeia.”
The show, which runs on Vice TV, allows him to bring life to stories and experiences of psychedelics along with the uses of these substances and their cultural significance and the chemistry behind them.
At the moment, Morris is a consultant at Compass Pathway’s Discover Center, which is based at Philadelphia’s University of the Sciences. There, he advises the company on research related to new psychedelic compounds that can be developed into treatments for unmet mental health needs.
Psychedelics Today CEO and cofounder, Joe Moore, stated that Morris was a good academic and cultural fit for the conference, noting that his views on ending the drug war, cognitive liberty and evidence-based policy, aligned with Psychedelics Today’s values. Psychedelics Today is a leader in psychedelic storytelling, media, education and events. The organization will be holding the conference, which will include a curated agenda with more than 60 expert speakers in research, advocacy, culture and business.
Announced speakers include Dr. Carl Hart; Steve DeAngelo, an activist, author and trailblazing marijuana entrepreneur; Ezekiel Golan, an activist and scientist; and Laura Dawn, a psychedelic retreat facilitator, plant medicine integration guide and host of “The Psychedelic Leadership Podcast.”
Additional speakers include the owner of Doorway Therapeutic Services, Courtney Watson, who is also a therapist; Zac Kamenetz, a community leader, rabbi and founder of Shefa Jewish Psychedelic Support; and managing director of PsychedeLiA Integration, Paul Antico.
Doorway Therapeutic Services is a therapy practice that addresses the mental health needs of Black, Indigenous and individuals of color as well as the LGBTQIA community.
The conference is set to run Oct. 20–23, 2022, in Los Angeles. Morris’ keynote will be held on the last day of the conference.
The conference’s full schedule will be released in the coming weeks as more speakers are announced. The event programming is holistic, with panels on research, ethics, business, veterans, therapeutic modalities/medical applications, policy, community, spirituality, Indigenous and diversity and inclusion.
Convergence will also include a concert series to celebrate individuals taking part in the modern psychedelic resurgence and the progress made thus far.
Visit psychedelicstoday.com/convergence to learn more about Convergence and see any updates.
Such conferences are a good facilitator of the proper flow of information between industry actors such as Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) and the general public, which appears to be hungrier than ever for science-backed information about the potential and risks associated with different psychedelic compounds.
NOTE TO INVESTORS: The latest news and updates relating to Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) are available in the company’s newsroom at https://ibn.fm/CYBN
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer
Convergence, the biggest psychedelic culture and business conference in California, recently announced that Hamilton Morris would be a keynote speaker at the conference. Morris is a well-known advocate in the psychedelics space. In addition to being a scientific researcher, a journalist and a filmmaker, he has a television show known as “Hamilton’s Pharmacopeia.”
The show, which runs on Vice TV, allows him to bring life to stories and experiences of psychedelics along with the uses of these substances and their cultural significance and the chemistry behind them.
At the moment, Morris is a consultant at Compass Pathway’s Discover Center, which is based at Philadelphia’s University of the Sciences. There, he advises the company on research related to new psychedelic compounds that can be developed into treatments for unmet mental health needs.
Psychedelics Today CEO and cofounder, Joe Moore, stated that Morris was a good academic and cultural fit for the conference, noting that his views on ending the drug war, cognitive liberty and evidence-based policy, aligned with Psychedelics Today’s values. Psychedelics Today is a leader in psychedelic storytelling, media, education and events. The organization will be holding the conference, which will include a curated agenda with more than 60 expert speakers in research, advocacy, culture and business.
Announced speakers include Dr. Carl Hart; Steve DeAngelo, an activist, author and trailblazing marijuana entrepreneur; Ezekiel Golan, an activist and scientist; and Laura Dawn, a psychedelic retreat facilitator, plant medicine integration guide and host of “The Psychedelic Leadership Podcast.”
Additional speakers include the owner of Doorway Therapeutic Services, Courtney Watson, who is also a therapist; Zac Kamenetz, a community leader, rabbi and founder of Shefa Jewish Psychedelic Support; and managing director of PsychedeLiA Integration, Paul Antico.
Doorway Therapeutic Services is a therapy practice that addresses the mental health needs of Black, Indigenous and individuals of color as well as the LGBTQIA community.
The conference is set to run Oct. 20–23, 2022, in Los Angeles. Morris’ keynote will be held on the last day of the conference.
The conference’s full schedule will be released in the coming weeks as more speakers are announced. The event programming is holistic, with panels on research, ethics, business, veterans, therapeutic modalities/medical applications, policy, community, spirituality, Indigenous and diversity and inclusion.
Convergence will also include a concert series to celebrate individuals taking part in the modern psychedelic resurgence and the progress made thus far.
Visit psychedelicstoday.com/convergence to learn more about Convergence and see any updates.
Such conferences are a good facilitator of the proper flow of information between industry actors such as Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) and the general public, which appears to be hungrier than ever for science-backed information about the potential and risks associated with different psychedelic compounds.
NOTE TO INVESTORS: The latest news and updates relating to Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) are available in the company’s newsroom at https://ibn.fm/CYBN
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer
